Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jan 21, 2010	shooter eric m	Director	Option Execute	15,000	15.80
Dec 16, 2008	yancopoulos george	Officer	Automatic Sell	74,859	16.40 - 16.42
Feb 6, 2012	goldberg murray a	Officer	Option Execute	40,913	16.80 - 24.86
Feb 14, 2012	mccorkle douglas s	Officer	Option Execute	35,000	16.80 - 21.92
Dec 17, 2012	mccorkle douglas s	Officer	Option Execute	5,000	16.80
Jan 9, 2013	powchik peter	Officer	Option Execute	5,752	16.80 - 21.25
Jul 25, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Sep 18, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Nov 20, 2012	stahl neil	Officer	Option Execute	54,500	16.80
Dec 17, 2012	stahl neil	Officer	Option Execute	5,952	16.80
Feb 14, 2012	stahl neil	Officer	Option Execute	50,000	16.80
Nov 21, 2012	terifay robert j	Officer	Option Execute	20,000	16.80
Dec 18, 2012	terifay robert j	Officer	Option Execute	5,952	16.80
Jul 27, 2012	terifay robert j	Officer	Option Execute	50,875	16.80 - 21.92
May 7, 2013	terifay robert j	Officer	Option Execute	16,923	16.80
May 6, 2013	van plew daniel p	Officer	Option Execute	32,950	16.80
Dec 20, 2012	van plew daniel p	Officer	Option Execute	2,050	16.80
Feb 20, 2009	baker charles a	Director	Automatic Sell	10,000	18.16
Oct 2, 2007	shooter eric m	Director	Sell	10,000	18.30 - 18.37
Mar 21, 2013	brown michael s	Director	Option Execute	15,000	18.61
Showing 201-220 of 624 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.